+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Patient Groups"

Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • January 2023
  • 36 Pages
  • Global
From
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • January 2023
  • 35 Pages
  • Global
From
Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 34 Pages
  • Global
From
Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 34 Pages
  • Global
From
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - USA Edition - The Views of 361 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - USA Edition - The Views of 361 USA Patient Groups

  • Report
  • May 2023
  • 50 Pages
  • United States
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Global Edition - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Global Edition

  • Report
  • April 2023
  • 138 Pages
  • Global
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

  • Report
  • November 2022
  • 54 Pages
  • Global
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis) - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

  • Report
  • November 2022
  • 57 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 UK Patient Groups

  • Report
  • July 2022
  • 59 Pages
  • United Kingdom
Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups - Product Thumbnail Image

Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups

  • Report
  • June 2022
  • 63 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups

  • Report
  • June 2022
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

  • Report
  • May 2022
  • 64 Pages
  • Global
Loading Indicator

The Patient Groups market within the context of Healthcare Services is a segment of the healthcare industry that focuses on providing services to specific patient populations. These services can include medical care, health education, and other support services. Patient Groups can be organized by age, gender, ethnicity, or other demographic factors. They can also be organized by medical condition, such as cancer, diabetes, or heart disease. The goal of Patient Groups is to provide tailored care and support to individuals with specific needs. The Patient Groups market is a growing segment of the healthcare industry, as it allows healthcare providers to better serve their patients. It also allows for more efficient use of resources, as providers can focus on providing services to specific patient populations. Some companies in the Patient Groups market include HealthPartners, Kaiser Permanente, and UnitedHealth Group. These companies provide a variety of services to their patients, including medical care, health education, and other support services. Show Less Read more